Coya Therapeutics, Inc. (COYA)
(Delayed Data from NSDQ)
$6.40 USD
-0.03 (-0.47%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $6.38 -0.02 (-0.31%) 6:26 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Coya Therapeutics, Inc. has a market cap of $107.54M, which represents its share price of $6.43 multiplied by its outstanding shares number of 16.73M. As a small-cap company, COYA's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
COYA 6.40 -0.03(-0.47%)
Will COYA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for COYA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for COYA
EyePoint Pharmaceuticals (EYPT) Reports Q2 Loss, Misses Revenue Estimates
Coya Therapeutics, Inc. (COYA) Surges 10.7%: Is This an Indication of Further Gains?
COYA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Coya Therapeutics, Inc. (COYA) Outperforming Other Medical Stocks This Year?
Wall Street Analysts See a 144.73% Upside in Coya Therapeutics, Inc. (COYA): Can the Stock Really Move This High?
What Makes Coya Therapeutics, Inc. (COYA) a New Buy Stock
Other News for COYA
Coya Therapeutics (COYA) Maintains Buy Rating with Target Price of $18 | COYA Stock News
Coya Therapeutics (COYA) Research Sheds Light on PD Immune Dysfunction | COYA Stock News
Coya Therapeutics publishes new research study on progression of Parkinson's
Coya Therapeutics Announces Publication of Scientific Research Linking Inflammation and ...
Sixteen new option listings on July 23rd